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Summary 
Expression of mRNA for eight cytokines was analyzed in an in vitro response-proliferation 
and Ig-secretion- of normal human B lymphocytes. This was made possible by the use of routine 
thymoma cells as helper cells in conjunction with human T  cell supernatant,  and the design 
of human DNA  sequence-specific primers  for RT-polymerase chain reaction,  mRNAs for 
interleukin (IL)2 and IL-4, but also for IL-lcx and IL-1/3 remained undetectable during the whole 
culture period in highly purified B cells prepared by a three-step purification protocol. However, 
tumor necrosis factor ot and IL-6 mRNAs peaked during days 1-3 after culture start and became 
undetectable after 5-6 d, shortly before bulk B cell proliferation  started to decline. In contrast, 
transforming growth factor/31 mRNA, after a progressive increase during the first few days, 
and IL-10 mRNA, after a peak on days 1-3, remained detectable in immunoglobulin (Ig)-secreting 
cultures throughout the observation  period of 22 d. Clonal analysis on 8-d cultures that had 
been seeded with single B cells by autocloning with the cell sorter, revealed that 85%  of 77 
B cell clones studied,  expressed TGF-/31 mRNA, and only 19% IL-IO mRNA. These findings 
show a differentiation  stage-related  cytokine program during a B cell response, whereby (a) B 
cells can become activated without IL-lcx or IL-1/3 expression; (b) mRNA for positive (IL-10) 
and negative (TGF-/31) autoregulatory factors coexists in cell populations  during the later phase 
of the response, although not necessarily in all B cell clones; and (c) normal Ig-secreting cells 
cease IL-6 expression in contrast to their malignant counterparts,  myeloma cells. 
U 
'ntil  cytokine production  was  first  demonstrated in 
EBV-transformed B cell lines (1), B lymphocytes were 
considered to be just effector cells of the immune system, 
producing Ig after activation by T lymphocytes. More recent 
studies showed the production of many cytokines in EBV- 
transformed and leukemic B cell lines (2-6), including IL-2 
(7). IL-1 and -6 have been reported to be autocrine growth 
factors for human myeloma cell lines (8, 9). A physiological 
and possible  immunoregulatory role for B  cell-produced 
cytokines was suggested, when it was found that cytokines, 
such as IL-1, -6, and -10, TNF-c~ and TGF-/3 could be ex- 
pressed by normal murine (10) and human B cells (4, 11-15). 
In the present study, we reinvestigated the expression of 
mRNA for various cytokines (IL-lcx,  -1/3, -2, -4, -6, and 
IL-10, TNF-cx and TGF-/3  0  during the different stages of 
an in vitro response of normal human B lymphocytes, from 
activation  of resting B cells to the differentiation  into Ig- 
secreting cells. For this purpose, we used an in vitro culture 
system in which murine mutant EL-4 thymoma cells stimu- 
late B lymphocyte proliferation and differentiation into high- 
rate Ig-secreting cells (16, 17), and analyzed cytokine mRNAs 
by means of KT-PCR. 
The mRNA of only four of the studied cytokines, but 
notably not that of IL-lot or -1/3, was detected in highly 
purified B cells. TNF-ot and IL-6 mRNA expression occurred 
transiently during the first few days of culture, whereas IL- 
10 and TGF/3-1 mRNA expression persisted in Ig-secreting 
cell cultures. In single cell-derived 8-d B cell clones, TGF/3-1 
mRNA was expressed by most of the clones, whereas IL-IO 
mRNA was only detected in a minor subset. The results show 
a  differentiation  stage-dependent B  lymphocyte cytokine 
program. 
Materials and Methods 
Cell Separations: Two Different B  Cell Populations 
Were Obtained 
B CellPopulation 1.  Mononuclear  cells  from the peripheral  blood 
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gradient (Pharmacia, Uppsala, Sweden). Adherent cells (monocytes) 
were depleted by 1-h incubation in petri dishes at 37~  in normal 
culture medium-10%  FCS and T  cells (E + fraction) were re- 
moved through rosetting with neuraminkhse-treated  sheep erythro- 
cytes for 1 h at 4~  After staining with FITC-conjugated Leu12 
mouse IgG1 (anti-CD19) mAb (Becton Dickinson & Co., Moun- 
tain View, CA), B lymphocytes were positively selected with a cell 
sorter (Epics V; Coulter Electronics, Hialeah, FL), as described (18). 
B cell populations thus obtained were typically >95% surface Ig + 
when  analyzed with  PE-conjugated  goat  anti-human  total  Ig 
(Becton Dickinson & Co.). 
B Cell Population 2.  Adherent cell depletion as above was per- 
formed in the presence of 0.1% NAN3, followed by T cell deple- 
tion as previously described.  CD19 + B cells were then positively 
selected with magnetic beads (PAN-B Dynabeads M-450; Dynal, 
Oslo, Norway) at 4~  detached using Detacha-beads (Dynal) for 
1 h at room temperature in the presence of 0.1% NaN3 to reduce 
B cell activation, and finally, after staining with FITC-conjugated 
goat F(ab')2 anti-human/z chain (Jackson ImmunoResearch Labo- 
ratories, West Grove, PA) or HTC-conjugated F(ab')2 anti-human 
Ig (Cappel Laboratories,  Cochranville, PA), B lymphocytes were 
positively selected with the cell sorter. 
CD5 + and CDS- B Cell Subpopulations.  These were obtained 
with the cell sorter by positive or negative selection with Leul an- 
tibody (Becton Dickinson & Co.) of CD19 § cells (18), purified 
by magnetic beads. 
CD3 + T  Cells.  CD + T  cells were sorted from the E + frac- 
tion with FITC-conjugated anti-CD3 mAb (Dakopatts, Glostrup, 
Denmark) and cultured with 10 ng PMA/ml and 5/zg PHA/ml 
(10  s cells/200/~1) for 4, 8, and 24 h, in order to prepare RT-PCR 
controls for I1,2,  -4, and -10, respectively. 
Adherent Cells.  Monocytes were recovered after separation from 
mononuclear cells by 1-h incubation on plastic dishes at 37~  in 
normal medium-10% FCS. Such cells were then cultured in the 
E1,4 system (1,000 cells/well).  Cells from the tumor cell line U937 
were used as positive RT-PCR control for lysozyme. 
B  Cell Cultures 
300 B cells or single B cells (CD19 § B cells, distributed with 
the Autoclone apparatus of the cell sorter [19]) were added to 200- 
/zl cultures (96-well, fiat-bottomed plates) together with 5  x  104 
irradiated (50 Gy), mutagenized, murine EI,4 thymoma cells (clone 
6.1.5.5.)  and 5%  T  cell supernatant  (from 10  ~ E + cells/ml, in- 
cubated for 36 h in the presence of 10 ng/ml PMA and 5/zg/ml 
PHA), as described (17). All cultures were performed at 37~  in 
5% CO2 and in RPMI 1640 medium (Gibco, Basel, Switzerland), 
supplemented with 2 mM t-glutamine,  10 mM Hepes buffer, 5 
x  10-s M B2-ME, 100 U/ml penicillin,  100 tig/ml streptomycin 
(all from Gibco), and 10% heat-inactivated FCS (Seromed, Berlin, 
Germany). To extend such E1,4 cultures, secondary cultures were 
set up by pooling, after 8 d, the B cells from a series of primary 
cultures, separating them from dead E1,4 cells and cell degradation 
products on a Ficoll gradient, and reculturing them (104 cells/well, 
200 #1) by adding fresh EL-4 cells and T cell supernatant as above. 
Detection  of Cell Proliferation  and Ig Secretion 
The number of total viable cells after various  culture periods 
was determined by trypan blue exclusion. To determine the number 
of B cells, cell counts from parallel cultures containing only EL-4 
cells were subtracted. Thymidine incorporation was measured ac- 
cording to standard procedure (17). EL-4 cells are thymidine-kinase 
deficient and thus do not incorporate thymidine. Ig levels in cul- 
ture supernatants were quantified with IgM, IgG, and IgA iso- 
type-specific ELISAs as described (19). 
RNA  Extraction 
At different time points, culture wells were pooled, transferred 
to Eppendorf tubes, and centrifuged. Total RNA was recovered 
after cell lysis in 100/A of guanidm"  e-thiocyanate buffer  by add phenol/ 
chloroform extraction, followed by ethanol precipitation (20). 
RT-PCR 
RNA was retrotranscribed after annealing with 0.1 nM oligo 
dT primers (10 met; B6ehringer Mannheim, Germany) in the pres- 
ence of 3 U of AMV KT (Promega Corp., Madison, WI), 25 U 
of RNAsin (Promega Corp.), 1 mM DTT, 100 #g/ml BSA, and 
1 mM of each deoxynucleotide (B6ehringer Mannheim) in a total 
volume of 25 #1 for I h at 42~  (21). Aliquots of the KT mixture 
were then amplified in a thermocycler (Techne Corporation, Dux- 
ford, Cambridge, UK) in a volume of 50/zl with 25 U/ml of Taq 
polymerase (Promega Corp.) diluted in the buffer supplied by the 
manufacturer, 100 #M of  each deoxynucleotide and 500 nM of each 
of the two primers (22). The cycling conditions were 0.8 min at 
94~  for denaturation, 0.8 min at temperatures between 58 and 
66~  for annealing,  depending on the ts4 of the pair of primers 
used (23),  and 0.8 min at 72~  for elongation. 
The primers, synthesized and purified at the University of  Geneva, 
Department of Microbiology, had the following sequences, 5' and 
3'  primers,  respectively:  B2  microglobulin  (32m), 1  CCCCC 
ACTGA  AAAAG  ATGAG  and  TCACT  CAATC  CAAAT 
GCGGC;  lysozyme, CCAAA  TGGGA GAGTG GTTAC  and 
TCAGC  GATGT TATCT TGCAG;  CD  2,  GTCTT  TGTGG 
CACTG CTCG and AGGAG GATGT TGGGA AGTTG; I1,1cr 
GAGGA AGAAA TCATC AAGCC and CATCT "IGGC,  C AGTCA 
CATAC;  IL-1B, CTGCG  TGTTG  AAAGA  TGATA  AG  and 
CCACA  TTCAG  CACAG  GACTC;  Ib2,  GCAAC  TCCTG 
TCTTG CATTG and AATGT GAGCA TCCTG GTGAG; I1,4, 
CTGTG CTCCG GCAGT TCTAC and ACGTA CTCTG GTTGG 
CTTCC; Ib6, GCCAG AGCTG TGCAG ATGAG and AGGAA 
CTCCT  TAAAG  CTGCG;  II,10,  AW_~T  TCGAG  ATCTC 
CGAGA and TTTGT AGATG CCTTT CTCTT GG; TGF-31, 
TTTCG  CCTTA  GCGCC  CACTG  and  TCCAG  CCGAG 
GTCCT  TGCGG;  and  TNF-o~,  CAGCC  CTCTG  GCCCA 
GGCAG and GGTGA GGAGC ACATG GGTGG. Primers for the 
amplification of Ig C regions were designed on exons 3 and 4 for 
IgM (ACCTG CCCTC GCCAC TGAAG and GCTGC CCCCT 
CTGCA TCCAC) and on exons 2 and 3 for IgG (CAAGG AGTAC 
AAGTG  CAAGG  and  AAGAA  GGAGC  CGTCG  GAGTC), 
respectively.  For the amplification of Ig V regions, the upstream 
primer was designed to recognize a consensus sequence on the 
CDK3  of the  V  region  (ACACG  GCCGT  GTATT ACTGT) 
(similar to reference 24), and the downstream primer to recognize 
sequences on the first exon of the respective Ig-isotype C regions: 
for IgM, GAATT CTCAC AGGAG ACGAG; for IgG, AGGTG 
TGCAC  GCCGC  TGGTC;  and  for  IgA,  AGACC  TTGGG 
GCTGG TCGGG. The primer pairs used were designed (a) in order 
to anneal to human and not to routine gene sequences or EL-4-de- 
rived sequences; (b) to span over introns to allow the detection of 
potential contaminating genomic DNA; and (c) to contain restric- 
tion sites to confirm PCR specificity (PC/Gene program; Intelli- 
Genetics,  Mountain View, CA). Digestion of all amplified cDNA 
1 Abbreviation used in this paper:/~2m, Be microglobulin. 
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in each case in the expected restriction fragments. RT-PC1L  with 
all the above-mentioned  primers on Eb4 mRNA led to no detect- 
able bands, thus confirming  their species  specificity  (data  not shown). 
For "nested PCR", 1/10 of the reaction volume of the primary 
PCR was added to a fresh PCK mix, containing the following 
5' and Y primers, respectively: IL-10, TTGTT GTTAA AGGAG 
TCCTT GC and TTGCT CTTGT TTTCA CAGC~ A; and TGF- 
B1, TCAAC GGGTT CACTA CCGGC and the same 3' primer 
as above. 
An aliquot of  PCK product (see  below) was then visualized  after 
electrophoresis through 2.0% agarose  gels  by staining  with ethidium 
bromide (25). To ensure the absence of sample contamination, an 
RNA extraction control (murine Eb4 cells alone) was run in par- 
allel to each PCR. 
Estimation  of Relative  cDNA  Amounts 
The RT-PCK signal generated by B2m mRNA was chosen to 
estimate the amounts  of cDNA obtained from different B cell 
samples, since B2m cDNA from equal numbers of B cells and 
plasma cells gave rise to similar band intensities after PCR (only 
two to three times higher in activated B and plasma cells than in 
resting B cells) and since human sequence-specific  primers could 
be designed. Moreover, the absence of 32m pseudo genes (26) pre- 
vents false interpretations of cDNA-PCR  signals in case of pos- 
sible contamination by genomic DNA. 
Results 
B  Cell Response in the EL-4  Culture System  and RT-PCR. 
Coculture of human B lymphocytes with irradiated mouse 
T  cells from a mutant EL-4 thymoma cell line and human 
T cell supernatant leads to their activation, proliferation, and 
differentiation into Ig-secreting cells (17-19).  In the present 
study, the number of B cells at culture start typically increased 
100-fold after 8 d (Fig. 1). Cells harvested after 8 d of culture 
and passed  over a Ficoll  gradient were found to be >95% 
cytoplasmic Ig +, morphologically plasmocytic, and surface 
CD19 §  bright cells. When recultured with 
fresh EL-4 cells  and T  cell  supernatant,  such cells  almost 
stopped proliferating, but continued to secrete Ig (100-200 
pg/24 h/cell) for 2 wk (26a). 
To detect significant changes in cytokine mRNA expres- 
sion at different times of the B cell response,  we chose the 
expression  of ~2m  mRNA  as  an  approximate  reference 
(within an error range of a factor of 2 to 3) for the relative 
amounts ofcDNA obtained at different activation stages and 
from different numbers of cells per culture (see Materials and 
Methods).  Adjustment of cDNA  from the B  cell  culture 
samples before PCR according to counted cell numbers resulted 
in  similar  32m  RT-PCR  signals  throughout  the  culture 
period (Fig. 1). IgM and IgG mRNA expression was found 
to increase in such samples between days 3 and 7. After 8 d, 
B cell degradation progressively occurred in primary EL-4/B 
cell cultures (see decrease oflg mRNA in Fig. 1). Conversely, 
in secondary cultures, Ig mRNA expression was found to 
remain constant until the end of the observation period (22 
d),  in accordance  with ongoing Ig secretion. 
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Figure 1.  Kinetics  of cell proliferation  in EL-4/B  cell cultures (graph) 
and IgM, IgG, and B2m mKNA expression  in EF4/B cell samples. The 
graph shows  thymidine  incorporation  (thin lines) and increase  of  viable  cell 
number (thick lines) in primary (continuous lines) and secondary  cultures 
(broken lines), as percent maximal  values (18,000 cpm/culture on day 7 
for 300 B cells/culture  at primary  culture  start; 120 times  the starting  cell 
number on day 16). Resuks  are expressed  as mean  values  from  four  different 
experiments,  cDNA was obtained  at the indicated  days  from  pooled  series 
of 30 replicate cultures set up as above. PCR with IgM, IgG, and B2m- 
specific primers was performed  for the shown amplification  cycles  with 
cDNA aliquots corresponding to the equivalent of 1,000 viable B cells 
as determined  by cell count (except for days 1-6, where cDNA prepara- 
tions were adjusted for B2m expression). Ethidium bromide-stained 
agarose gels in this and the following  experiments  were prepared with 
1/10 of the volume  of the PCR mix. This  experiment  with B cell  popula- 
tion 1 cells  is representative  of similar  experiments  performed  with either 
B cells  from B cell population 1 (three  experiments)  or B cell population 
2 (three  experiments)  (see Materials  and Methods). (M) Molecular  weight 
marker (DNA molecular  weight  marker V, B6ehringer  Mannheim); (C) 
RNA extraction  control (mouse EL-4 thymoma  cells only). 
Correlation of lL-2 and -4 mRNA  with CD2 mRNA  Ex- 
pression.  Expression of mRNA of the T cell cytokines IL-2 
and -4 was barely detectable in 1,000 B cells from B cell popu- 
lation 1 (see Materials and Methods) at a detection limit of 
cDNA from 1 and 10 PMA/PHA-activated T cells for IL-2 
and -4,  respectively (Fig.  2).  A  similar weak expression in 
B cell cultures was found for the T cell marker CD2. IL-2, 
IL-4, and CD2 cDNA signals were undetectable in B cells 
from B cell population 2 (data not shown). Thus, IL-2 and 
-4 mRNA were not expressed by the B cells in this culture 
system. 
Correlation of  lL-Ic~ and-l~ mRNA with Lysozyme mRNA 
Expression.  EL-4/B cell cultures set up with B cells from 
B cell population 1 revealed clearly detectable IL-lot and -1B Figure  2.  Comparison of T  cell cytokine mKNAs (11.2 
and 11.4) in B cell cultures and T cells. PCR was performed 
with cDNA samples from B cell cultures (left; same experi- 
ment as in Fig. 1; cDNA from ,,ol,000  B cell population 1 
cells per PCK) and with serial dilutions of cDNA from purified 
CD3 + T  cells, that had been stimulated with PMA/PHA 
(see Materials and Methods; from 1-104 T  cell equivalents; 
right). (Arrow) Amplified  fragments from genomic DNA con- 
taminants.  These  were only detectable  in  the  IL-2 PCR. 
Amplified  cDNA fragments migrate further on the gel (com- 
pare with right). 
mRNAs from the beginning of the culture until day 3. How- 
ever, analysis  of mKNA for the monocyte/macrophage  marker 
lysozyme in these B cell cultures, and comparison with U937 
cells, at a detection limit of cDNA from I to 10 U937 cells, 
indicated  a  monocyte contamination of  *1%  (data  not 
shown). When adherent cells were added to the EL-4 cul- 
ture system, they expressed IL-la and -1/3 mRNA with very 
similar kinetics (Fig. 3). Thus, it was not possible to exclude 
that the IL-1 mKNAs in EL-4/B ceU cultures were derived 
from contaminating monocytes. To further investigate this 
point, we performed a more elaborate B cell purification. B 
calls were obtained by (a) depletion of monocytes by adher- 
ence and of T cells by SRBC rosetting; (b) positive selection 
with anti-CD19 magnetic beads;  and (c) FACS  |  sorting of 
membrane IgM or total Ig  +cells with goat F(ab')2 reagents 
(see Materials and Methods). In pooled mRNA, representing 
1/10 of the mRNA from 10,000 such B cells (named B cell 
population 2), we could no longer detect lysozyme mRNA. 
In addition, IL-lc~ and -1/3 mRNAs were also no more de- 
tectable (Fig. 3). Thus the IL-1 mRNAs could not be attrib- 
uted to B cells in this culture system. 
Time Pattern of lL-6,  TNF~, IL-IO, and TGF-~I mRNA 
Expression in EL-4/B Celt Cultures.  We detected mRNAs 
for four cytokines with two different time patterns in EL- 
4/B cell cultures set up with highly purified B cells (B cell 
population 2) (Fig. 4). (a) IL-6 and TNF-o~ mRNAs were 
upregulated between days 0 and 1, showed maximal expres- 
sion during days 1-3, and became undetectable on days 5-6. 
(b)  IL-10 mRNA (after  a peak on days 1-3) and TGFfl-1 
mRNA (after a progressive increase during the first 5 d) re- 
mained detectable until the end of the observation period (day 
22).  Thus, only the latter two cytokine mRNAs were de- 
tectable  in cultures with Ig-secreting cells throughout the 
secondary culture. 
A comparison with myeloma cells (U266 and RPMI 8226 
cell lines), as well as with PMA/PHA-activated T cells, showed 
similar IL-10 mRNA expression  for the same numbers of 
normal Ig-secreting, myeloma, and T cells. Thus, the require- 
ment for nested PCR for IL-10 mRNA detection may be 
due to the lower efficiency of the selected human cDNA- 
specific primers rather than to effective mRNA levels. IL-6 
mRNA was  detectable  in U266  myeloma cells  (data  not 
shown). 
Contrary to the findings of a study with routine B cells 
(27), the analysis of EL-4/B cell cultures set up with sorted 
CD5 +  and  CDS-  B  cells showed no difference  in  IL-10 
mRNA expression between the two subsets of cells (data not 
shown). 
Analysis of  lL-IO and TC,  F/3-I mRNA Expression  in Individual 
B Celt Clones.  By clonal analysis, we studied whether the 
same cell clones produce mtLNAs for IL-10  and TGF/3-1. 
EL-4 cultures with single CD19 + B cells were set up with 
Figure  3.  Absence of Iblcx and 
-1B mKNA in highly purified B 
cells. (Left) PCR for the detection 
of IL.lo~, IL-1B, lysozyme, and B2m 
cDNAs was performed with cDNA 
from adherent cells and from highly 
purified B cells (B cell population 
2) cultured for the indicated time 
periods in the Eb4 system, cDNA 
samples  corresponded to  ,~1,000 
cells  per  PCR.  Two  consecutive 
rounds  of PCP, amplification (30 
and 20 cycles)  were done for the de- 
tection  of lysozyme cDNA.  The 
cDNA detection limits were estab- 
lished with U937 cells (right). 
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culture, cDNA samples were adjusted for ~2m signals and corresponded 
to cDNA from ,vl,000 B cells (see Fig. 1). Results obtained after two 
different numbers of amplification cycles, before complete  saturation  of 
bands from all samples, are shown. Nested PCR was performed for the 
detection of Ibl0 mRNA. (Reaction  1) PCIL for 30 cycles; (reaction 2) 
PCR for 12 and 22 cycles, respectively. The results for TNF-c~, IL-6, and 
1I:10 mRNA were obtained with B cell population 2 cells and are repre- 
sentative for  two other experiments  with total surface Ig  + or surface 
IgM + B cell population 2 cells. The results for TGFI3-1 were obtained 
with B cell population I cells, but B cell population 2 cells gave the same 
band pattern. 
the Autodone device of the cell sorter.  After 8 d, Ig levels 
were measured by ELISA assays and Ig secretion was detected 
in 77 of 140 tested cultures (IgM in 5,  IgM and IgG in 6, 
IgM and IgA in 11, IgM, IgG, and IgA in 31, IgG in 7, IgA 
in 10, and IgG and IgA in 7 cultures). These results show 
a B cell responder frequency of 55%  and frequent IgM to 
IgG or IgM to IgA isotype switch, in accordance with our 
previous autocloning results (19). cDNA preparations were 
made from all Ig + wells and 13zm mRNA was detected in 
95% of them. mRNA or cell degradation before day 8 pos- 
sibly occurred in the remaining Ig + cultures. On the other 
hand, in 10 cDNA samples prepared from Ig- culture wells, 
no ~2m signal was detected. RT-PCR with V and C region 
primer pairs detected clonal IgM, IgG, and/or IgA mRNA 
bands in 20 Ig ELISA-positive cultures analyzed, as opposed 
to smears obtained with B cell bulk cultures (examples are 
Figure 5.  Typical RT-PCR results from single B cell clones. Single B 
cells were seeded in EI~4 cultures with the use of the Autoclone apparatus 
of the cell sorter, and cultured for 8 d. RNA from culture wells, in which 
Ig secretion had been detected by ELISA, was analyzed by RT-PCR for 
the presence of the indicated mRNAs. PCR input corresponded to 1/4 
of the total  ILT volume for IL-10 and TGF-B1, and to 1/10 of the RT 
volume for BT.rn  and IgM, IgG, and IgA. Positive control, (B), is cDNA 
from an EL-4/B cell bulk culture (equivalent of 1,000 B cells/PCR; day 
8). Note that Ig-PCRs with the chosen primers results in smeared bands 
for polyclonal B cells, in contrast to the monoclonal band patterns in an- 
toclone wells. Nested PCR was performed for the detection of IL-10 and 
TGF-B1 mRNA. 
shown in Fig. 5). These results were in accordance with the 
ELISA results. 
TGFI3-1 mKNA was detectable by nested PCK in 85% 
of Ig ELISA-  and 132m mRNA-positive cultures, whereas 
IL-10 mRNA was found in only 19% of such cultures (Fig. 
6).  All cultures containing detectable IL-IO mKNA coex- 
pressed TGF~-I mKNA. No correlation between secreted 
Ig isotypes and the presence of TGF/3-1 and IL-10 mRNA 
could be established. Also, the presence of IL-10 mRNA was 
not correlated with strong 13zm mKNA signals or high Ig 
levels. Thus, absence oflL-10 mRNA seemed not to be related 
to small B cell clones. The number of clones with detectable 
IL-10 mRNA did not change over a 10-fold difference of PCK 
amplification cycles (inset, Fig. 6). The data strongly suggest 
that, whereas almost all B cell clones express TGFB-1, addi- 
tional IL-10 expression  occurs at this time point only in a 
subset  of such clones. 
Discussion 
The analysis of cytokine mRNA expression in normal 
human B lymphocytes during a T cell-dependent response 
was made possible by the use of murine thymoma cells as 
helper cells in conjunction with human T cell supernatant, 
and the design of human cDNA sequence-specific primers 
for RT-PCR. Recent experiments showed that our mutant 
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mRNAs expressing  B cell clones. The 77 autoclone 
culture wells, in which Ig secretion had been de- 
tected by ELISA and Bzm mRNA by RT-PCR, 
were tested for Ibl0 and TGF'-/~I  mRNA expres- 
sion, as shown in Fig. 5. All I1--10  mRNA posi- 
tive clones also contained TGF-~I mRNA. The 
percentage of  positive  wells  is depicted  and the mean 
Ig production per culture well is indicated. (Inset) 
Nested  PCR  results  for  the detection  of Ib-10 
mRNA from 8 B cell clones after 30 plus 12 and 
after 30 plus 22 cycles. Note that the presence or 
absence of bands did not change over the 10-cycle 
interval.  The mRNA equivalent from  10 EBV- 
transformed B cells was run as a positive RT-PCR 
control (10 c). 
EL-4 thymoma cells express CD40 ligand in a way similar 
to normal helper T cells, and that their helper activity is to- 
tally inhibited by murine or human soluble CD40-Ig Fc con- 
structs (Werner-Favre, C., J. F. Gauchat, G. Mazzei, J.  Y. 
Bonnefoy, and R. H. Zubler, unpublished results). Thus, like 
another assay for e~cient human B cell activation (28),  this 
system involves  a CD40-mediated B  cell activation signal. 
However, long-term growth of B cells (28) does not occur 
in the EL-4 system. 
mRNA expression for eight cytokines was studied. IL-2 
and IL-4 mRNAs can, most probably, not be attributed to 
B cells. This contrasts with findings on EBV-immortalized 
B cells, which were found to produce IL-2 and -4 mRNAs 
(29),  and IL-2 bioactivity (7), but no IL-4 immunoreactive 
protein (29).  More unexpectedly, the presence of IL-lc~ and 
-1B mRNAs in EL-4/B cell cultures correlated with that of 
the monocyte marker lysozyme. B cell population  1 cells, 
which contained '~1%  of monocytes, expressed IL-lc~  and 
-1B mRNAs, whereas triple-isolated B cell population 2 cells 
without detectable lysozyme mRNA showed no IL-1 expres- 
sion. This also differs from observations on EBV-transformed 
B cells (11, 29).  In addition, IL-l-like bioactivity (11), im- 
munoreactive IL-1, and IL-lo~ and -1~ mRNAs (by Northern 
blot) have previously been detected in normal human B cells 
(12).  The latter observations were made with B cells acti- 
vated with anti-Ig antibody. The absence of IL-1 mRNAs 
and the presence of the other cytokine mRNAs,  as found 
with the EL-4 system in the presence of total T cell superna- 
rant, were confirmed with a system (28) that uses IL-4 and 
murine fibroblasts  coated with anti-CD40 antibody (our un- 
published results). Thus, IL-1 expression is at least not oblig- 
atory during a B cell response. It can be asked whether IL-1 
expression in normal B cell populations is always due to mono- 
cyte contamination. This is not yet clear, but if it were the 
case, it would be in accord with the reported difference in 
in vivo effects on naive, resting T  cells of antigen presenta- 
tion by B cells versus that by macrophages in mice (30, 31). 
Four cytokine mRNAs with two different time patterns 
of expression were detected in  B  cells.  TNF-o~  and  IL-6 
mRNAs peaked during days 1-3  and became undetectable 
after 5-6 d, shortly before the bulk B cell proliferation declined. 
In  contrast,  TGFfl-1  mRNA,  after a progressive increase 
during the first few days,  and IL-IO mRNA,  after a peak 
on days 1-3,  remained detectable throughout the observa- 
tion  period  of 22  d.  This  shows  a  B  cell differentiation 
stage-related cytokine program. Previous studies have revealed 
that B cells can effectively synthesize (and also respond to) 
these cytokines (4, 13-15, 32, 33). It becomes therefore difficult 
to predict the relative dependence on exogenous (T cell and 
monocyte-derived)  cytokines during an in vivo B cell response. 
In a recent study on the effects of adding various cytokines 
and cytokine inhibitors to B cells cocultured with EL-4 thy- 
moma cells in the absence of T  cell supernatant, we found 
that IL-1 was required to induce TNF-ol responsiveness of 
B cells, and that TNF-o~ was required to induce responsive- 
ness to other cytokines such as IL-2, -4,  and -6 (34).  This 
hierarchy of cytokine effects fits with the occurrence of the 
IL-1 mlLNA peak (at 6 h) before the TNF-ot mRNA peak 
(days 1-3) in B cell population 1 cells. However, the results 
obtained with B cell population 2 cells show that the IL-1 
is an exogenous cytokine in this system. It is possible  that 
various activation signals differentially  influence cytokine ex- 
pression by B cells. 
Clonal analysis,  performed by RT-PCR on 8-d cultures 
that had been seeded with single B cells by autocloning with 
the cell sorter, showed that most Ig-secreting B cell clones 
express TGFfl-1 mRNA (85%), and only 19% IL-10 mRNA. 
Both TGFfl-1 and IL-10 were found to influence isotype switch 
to IgA (35),  but no correlation between the expression of 
these cytokine mRNAs and secreted Ig isotypes (IgM, IgG, 
526  Cytokine mRNA in Normal Human B Lymphocytes and IgA) or amounts of Ig could be established. It is known 
that  adult versus cord blood-derived CD19 + B cells (36), 
and  CD19 +  total  B  cells versus membrane  IgM +  B  cells 
(>85%  of adult  CD19 + B  cells)  (19)  switch to other iso- 
types with very similar high frequencies in the present cul- 
ture system and even produce similar proportions of clones 
producing only IgG or IgA (derived from IgM/G or IgM/A 
double isotype-positive cells). Thus the present data are only 
representative for naive B cells. CD5 + but not CDS- B cells 
were found to be the main source of IL-10 mKNA in mouse 
I3 lymphocytes (27). Our experiments with bulk cultures of 
sorted CD5 + and CD5-  B cells did not show such a differ- 
ence. However, in human B cells, the CD5 molecule behaves 
like an activation marker rather than a marker for a special 
B cell lineage (18, 37), and most CDS- B cells become tran- 
siently CD5 + during the first few days in the EL-4 culture 
system (18). IL-10 mRNA is in fact also increased at that time. 
TGF~-I was shown to inhibit (14) whereas IL-IO was found 
to stimulate human B cell growth and Ig secretion (38). These 
opposite effects of TGFB-1 (34) and IL-10 (our unpublished 
results) were confirmed in the EL-4 system. Our bulk cul- 
ture data thus suggest that positive and negative autoregula- 
tory factors coexist during the whole B cell response, as in 
many other biological systems. But it is not known whether 
plasmocytic cells or a minor subset of less differentiated cells 
express TGF/~-I and/or IL-IO mKNA.  Also, it is not dear 
whether B cell clones only differ with regard to cell differen- 
tiation or whether they are heterogeneous regarding cytokine 
expression like T cell clones (the TGF/3-1 and IL-10 mKNAs 
remained  detectable until  day 22). 
In agreement with previous studies (8, 39) our data show 
that normal Ig-secreting cells produce neither IL-1 nor -6, 
and,  therefore, clearly differ from their malignant  counter- 
parts, myeloma cells (8, 9). It has recently been reported that 
detectable serum IL-IO indicates a better, and detectable serum 
IL-6 a worse, prognosis in multiple myeloma patients (40). 
According to the differentiation stage-related cytokine pro- 
gram of normal B cells shown above, IL-6-producing my- 
eloma  cells  should  be  less  differentiated  than  IL-6-non- 
producing  myeloma cells. 
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